ANGPTL8 protein-truncating variant and the risk of coronary disease, type 2 diabetes and adverse effects

Pyry Helkkula, Tuomo Kiiskinen, Aki S. Havulinna, Juha Karjalainen, Seppo Koskinen, Veikko Salomaa, FinnGen, Mark J. Daly, Aarno Palotie, Ida Surakka, Samuli Ripatti
doi: https://doi.org/10.1101/2020.06.09.20125278

Data Availability

The FinnGen data may be accessed through the FinnBB portal (www.finbb.fi) of the Finnish Biobanks and THL Biobank data through THL Biobank (https://thl.fi/en/web/thl-biobank).

https://www.finbb.fi/

https://thl.fi/en/web/thl-biobank

Back to top
Posted June 12, 2020.
Download PDF

Supplementary Material

Data/Code
Email
ANGPTL8 protein-truncating variant and the risk of coronary disease, type 2 diabetes and adverse effects
Pyry Helkkula, Tuomo Kiiskinen, Aki S. Havulinna, Juha Karjalainen, Seppo Koskinen, Veikko Salomaa, FinnGen, Mark J. Daly, Aarno Palotie, Ida Surakka, Samuli Ripatti
medRxiv 2020.06.09.20125278; doi: https://doi.org/10.1101/2020.06.09.20125278
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area